These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 23664559)

  • 21. Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis.
    Kalinina Ayuso V; van de Winkel EL; Rothova A; de Boer JH
    Am J Ophthalmol; 2011 Feb; 151(2):217-22. PubMed ID: 21145533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Methotrexate treatment in refractory juvenile rheumatoid arthritis].
    Brik R
    Harefuah; 1998 Dec; 135(11):509-11, 567. PubMed ID: 10911466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines.
    Heiligenhaus A; Niewerth M; Ganser G; Heinz C; Minden K;
    Rheumatology (Oxford); 2007 Jun; 46(6):1015-9. PubMed ID: 17403710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease.
    Ravelli A; Felici E; Magni-Manzoni S; Pistorio A; Novarini C; Bozzola E; Viola S; Martini A
    Arthritis Rheum; 2005 Mar; 52(3):826-32. PubMed ID: 15751057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis.
    Céspedes-Cruz A; Gutiérrez-Suárez R; Pistorio A; Ravelli A; Loy A; Murray KJ; Gerloni V; Wulffraat N; Oliveira S; Walsh J; Penades IC; Alpigiani MG; Lahdenne P; Saad-Magalhães C; Cortis E; Lepore L; Kimura Y; Wouters C; Martini A; Ruperto N;
    Ann Rheum Dis; 2008 Mar; 67(3):309-14. PubMed ID: 17875547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis.
    Bulatovic M; Heijstek MW; Van Dijkhuizen EH; Wulffraat NM; Pluijm SM; de Jonge R
    Ann Rheum Dis; 2012 Sep; 71(9):1484-9. PubMed ID: 22473625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.
    Tynjälä P; Vähäsalo P; Tarkiainen M; Kröger L; Aalto K; Malin M; Putto-Laurila A; Honkanen V; Lahdenne P
    Ann Rheum Dis; 2011 Sep; 70(9):1605-12. PubMed ID: 21623000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for the development of cataract requiring surgery in uveitis associated with juvenile idiopathic arthritis.
    Sijssens KM; Rothova A; Van De Vijver DA; Stilma JS; De Boer JH
    Am J Ophthalmol; 2007 Oct; 144(4):574-9. PubMed ID: 17706583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended oligoarthritis and other risk factors for developing JIA-associated uveitis under ILAR classification and its implication for current screening guideline.
    Sim KT; Venning HE; Barrett S; Gregson RM; Amoaku WM
    Ocul Immunol Inflamm; 2006 Dec; 14(6):353-7. PubMed ID: 17162606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry.
    Henderson LA; Zurakowski D; Angeles-Han ST; Lasky A; Rabinovich CE; Lo MS;
    Pediatr Rheumatol Online J; 2016 Feb; 14(1):9. PubMed ID: 26879972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease of the year: juvenile idiopathic arthritis-associated uveitis--classification and diagnostic approach.
    Tugal-Tutkun I; Quartier P; Bodaghi B
    Ocul Immunol Inflamm; 2014 Feb; 22(1):56-63. PubMed ID: 24410427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis.
    Zulian F; Balzarin M; Falcini F; Martini G; Alessio M; Cimaz R; Cimino L; Zannin ME
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):821-5. PubMed ID: 20191477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.
    Ruperto N; Murray KJ; Gerloni V; Wulffraat N; de Oliveira SK; Falcini F; Dolezalova P; Alessio M; Burgos-Vargas R; Corona F; Vesely R; Foster H; Davidson J; Zulian F; Asplin L; Baildam E; Consuegra JG; Ozdogan H; Saurenmann R; Joos R; Pistorio A; Woo P; Martini A;
    Arthritis Rheum; 2004 Jul; 50(7):2191-201. PubMed ID: 15248217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept.
    Borte S; Liebert UG; Borte M; Sack U
    Rheumatology (Oxford); 2009 Feb; 48(2):144-8. PubMed ID: 19074187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uveitis and anti nuclear antibody positivity in children with juvenile idiopathic arthritis.
    Kasapçopur O; Yologlu N; Ozyazgan Y; Ercan G; Caliskan S; Sever L; Ozdogan H; Arisoy N
    Indian Pediatr; 2004 Oct; 41(10):1035-9. PubMed ID: 15523130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of medication withdrawal method on flare-free survival in patients with juvenile idiopathic arthritis on combination therapy.
    Chang CY; Meyer RM; Reiff AO
    Arthritis Care Res (Hoboken); 2015 May; 67(5):658-66. PubMed ID: 25220674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Female sex and oligoarthritis category are not risk factors for uveitis in Italian children with juvenile idiopathic arthritis.
    Calandra S; Gallo MC; Consolaro A; Pistorio A; Lattanzi B; Bovis F; Muratore V; De Marco R; Martini A; Ravelli A
    J Rheumatol; 2014 Jul; 41(7):1416-25. PubMed ID: 24931957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti-tumor necrosis factor alpha agents.
    Lurati A; Pontikaki I; Teruzzi B; Desiati F; Gerloni V; Gattinara M; Cimaz R; Fantini F
    Arthritis Rheum; 2006 May; 54(5):1602-7. PubMed ID: 16646003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment.
    van Rossum MA; van Soesbergen RM; Boers M; Zwinderman AH; Fiselier TJ; Franssen MJ; ten Cate R; van Suijlekom-Smit LW; Wulffraat NM; van Luijk WH; Oostveen JC; Kuis W; Dijkmans BA;
    Ann Rheum Dis; 2007 Nov; 66(11):1518-24. PubMed ID: 17491099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Azathioprine as a treatment option for uveitis in patients with juvenile idiopathic arthritis.
    Goebel JC; Roesel M; Heinz C; Michels H; Ganser G; Heiligenhaus A
    Br J Ophthalmol; 2011 Feb; 95(2):209-13. PubMed ID: 20584711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.